+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Foot & Mouth Disease Vaccines Market by Product, Type, Application, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4829815
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Foot & Mouth Disease Vaccines Market grew from USD 2.69 billion in 2023 to USD 2.93 billion in 2024. It is expected to continue growing at a CAGR of 9.10%, reaching USD 4.95 billion by 2030.

Foot & Mouth Disease (FMD) vaccines are pivotal in livestock health management, providing immunity against a highly contagious viral disease impacting cloven-hoofed animals. The scope encompasses vaccines tailored to different virus serotypes, including inactivated vaccines, immune-modulating agents, and advancements in synthetic peptide vaccines. The necessity of FMD vaccines is underscored by the devastating economic impacts of outbreaks, influencing livestock sectors by curbing productivity and trade. These vaccines find application primarily in agriculture and veterinary healthcare, particularly among cattle, pigs, sheep, and goats. Market segmentation focuses on end-users such as commercial farms, veterinary clinics, government organizations, and research institutes. Growth factors include the increasing incidence of FMD incidences and improved government regulations fostering vaccine uptake. Recently, technological innovations, like recombinant vaccines, are creating lucrative opportunities, while regional animal vaccination programs are gaining momentum. However, market growth is restrained by challenges like the high cost of vaccination programs, vaccine storage demands, and the ongoing need for continuous epidemiological surveillance. The rigidity of cold chain logistics in rural areas further complicates vaccine distribution. Innovation should focus on the development of more cost-effective vaccines with higher efficacy rates, long-lasting immunity, and applicability across multiple strains. Research areas could include nanotechnology applications in vaccine delivery and enhanced diagnostic technologies for better disease tracking and management. The FMD vaccine market presents a landscape ripe for biotechnological advancements that address existing limitations while offering promising avenues for business expansion. Collaborations between governments, academic institutions, and private enterprises could accelerate this progress, driving strategic developments. In essence, despite the challenging factors, the market exhibits a dynamic and evolving nature, demanding informed strategic interventions to harness upcoming opportunities effectively.

Understanding Market Dynamics in the Foot & Mouth Disease Vaccines Market

The Foot & Mouth Disease Vaccines Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing prevalence and incidence of FMD outbreaks across the globe
    • Availability of government policies for mandatory vaccinations that promote animal health
  • Market Restraints
    • Concerns related to thermal instability and short-lived immunity
  • Market Opportunities
    • Increasing investments in R&D to yield advanced vaccines for FMD
    • Growing government approvals for FMD vaccines
  • Market Challenges
    • Risk of recombination with the wild strains

Exploring Porter’s Five Forces for the Foot & Mouth Disease Vaccines Market

Porter’s Five Forces framework further strengthens the insights of the Foot & Mouth Disease Vaccines Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Foot & Mouth Disease Vaccines Market

External macro-environmental factors deeply influence the performance of the Foot & Mouth Disease Vaccines Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Foot & Mouth Disease Vaccines Market

The Foot & Mouth Disease Vaccines Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Foot & Mouth Disease Vaccines Market

The Foot & Mouth Disease Vaccines Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Foot & Mouth Disease Vaccines Market

The Foot & Mouth Disease Vaccines Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Foot & Mouth Disease Vaccines Market, highlighting leading vendors and their innovative profiles. These include Bharatbiotech International Ltd., Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Botswana Vaccine Institute, Brilliant Bio Pharma, Brilliant Bio Pharma Pvt. Ltd., China Animal Husbandry Group, Indian Immunologicals Ltd., Inner Mongolia Biwei Antai Biotechnology Co., Ltd., Inovio Pharmaceuticals, Inc., Jinyu Baoling Biopharmaceutical Co., Ltd., Laboratorios Bagó S.A., Limor de Colombia, Merck KGaA, Merial S.A.S., MorphoSys AG, QYH Biotech Co., Ltd., Shenlian Biopharmaceutical (Shanghai) Co., Ltd., Vallée S.A., Vetal Animal Health Products S.A., and Veterinary Serum and Vaccine Research Institute.

Market Segmentation & Coverage

This research report categorizes the Foot & Mouth Disease Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Conventional
    • Emergency
  • Type
    • DNA Vaccines
    • Inactivated Vaccines
    • Live Attenuated Vaccines
    • Live Viral Vector Vaccines
    • Peptide Vaccines
  • Application
    • Cattle
    • Goat
    • Pigs
    • Sheep
  • Distribution Channel
    • Government Institutions
    • Veterinary Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence and incidence of FMD outbreaks across the globe
5.1.1.2. Availability of government policies for mandatory vaccinations that promote animal health
5.1.2. Restraints
5.1.2.1. Concerns related to thermal instability and short-lived immunity
5.1.3. Opportunities
5.1.3.1. Increasing investments in R&D to yield advanced vaccines for FMD
5.1.3.2. Growing government approvals for FMD vaccines
5.1.4. Challenges
5.1.4.1. Risk of recombination with the wild strains
5.2. Market Segmentation Analysis
5.2.1. Product: Burgeoning utilization of emergency vaccines offering a quick solution to unexpected incursions of the disease
5.2.2. Distribution Channel: Evolving veterinary clinics for the distribution of foot and mouth disease vaccines
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Foot & Mouth Disease Vaccines Market, by Product
6.1. Introduction
6.2. Conventional
6.3. Emergency
7. Foot & Mouth Disease Vaccines Market, by Type
7.1. Introduction
7.2. DNA Vaccines
7.3. Inactivated Vaccines
7.4. Live Attenuated Vaccines
7.5. Live Viral Vector Vaccines
7.6. Peptide Vaccines
8. Foot & Mouth Disease Vaccines Market, by Application
8.1. Introduction
8.2. Cattle
8.3. Goat
8.4. Pigs
8.5. Sheep
9. Foot & Mouth Disease Vaccines Market, by Distribution Channel
9.1. Introduction
9.2. Government Institutions
9.3. Veterinary Clinics
10. Americas Foot & Mouth Disease Vaccines Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Foot & Mouth Disease Vaccines Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Foot & Mouth Disease Vaccines Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Indian Immunologicals’ new facility for FMD vaccines to come up in Hyderabad’s Genome Valley
13.3.2. Biogénesis Bagó reaches a new milestone in its fight against Foot and Mouth Disease
13.3.3. Indonesia launching nationwide vaccinations for foot and mouth disease
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. FOOT & MOUTH DISEASE VACCINES MARKET RESEARCH PROCESS
FIGURE 2. FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. FOOT & MOUTH DISEASE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. FOOT & MOUTH DISEASE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. FOOT & MOUTH DISEASE VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. FOOT & MOUTH DISEASE VACCINES MARKET DYNAMICS
TABLE 7. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY EMERGENCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY LIVE VIRAL VECTOR VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PEPTIDE VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY GOAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PIGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY SHEEP, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY GOVERNMENT INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. CANADA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. MEXICO FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. CHINA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. INDIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. JAPAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. THAILAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. DENMARK FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. EGYPT FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. FINLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. FRANCE FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. GERMANY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. ITALY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. NORWAY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 150. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. POLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. QATAR FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 170. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SPAIN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. TURKEY FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM FOOT & MOUTH DISEASE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. FOOT & MOUTH DISEASE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 193. FOOT & MOUTH DISEASE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Foot & Mouth Disease Vaccines market, which are profiled in this report, include:
  • Bharatbiotech International Ltd.
  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Botswana Vaccine Institute
  • Brilliant Bio Pharma
  • Brilliant Bio Pharma Pvt. Ltd.
  • China Animal Husbandry Group
  • Indian Immunologicals Ltd.
  • Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
  • Inovio Pharmaceuticals, Inc.
  • Jinyu Baoling Biopharmaceutical Co., Ltd.
  • Laboratorios Bagó S.A.
  • Limor de Colombia
  • Merck KGaA
  • Merial S.A.S.
  • MorphoSys AG
  • QYH Biotech Co., Ltd.
  • Shenlian Biopharmaceutical (Shanghai) Co., Ltd.
  • Vallée S.A.
  • Vetal Animal Health Products S.A.
  • Veterinary Serum and Vaccine Research Institute

Methodology

Loading
LOADING...

Table Information